Hims & Hers Health Inc (HIMS)

$27.39 -1.22 (-4.26%)
Market Cap 6.68B
Revenue (ttm) 2.35B
Net Income (ttm) 128.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 5.47%
Debt to Equity Ratio 0.00
Volume 7,932,200
Avg Vol 15,742,214
Day's Range N/A - N/A
Shares Out 233.31M
Stochastic %K 0%
Beta 2.40
Analysts Sell
Price Target $31.69

Company Profile

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health a...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 415 851 0195
Address:
2269 Chestnut Street, Suite 523, San Francisco, United States
ChristineMartinez757
ChristineMartinez757 Aug. 19 at 9:15 AM
$HGRAF $KORU $LLY $HIMS HGRAF remains highly speculative, KORU remains speculative and execution-dependent, Eli Lilly benefits from strong obesity and diabetes-drug demand, and Hims & Hers benefits from digital-health adoption. I'm watching liquidity, prescription growth, customer additions, regulatory developments, and margins.
0 · Reply
NathanUziel1102
NathanUziel1102 Aug. 19 at 9:12 AM
$SNDQ $HIMS $SOXS $PYPL SNDQ provides semiconductor exposure, Hims & Hers benefits from digital-health demand, SOXS provides leveraged inverse semiconductor exposure, and PayPal remains tied to digital payments and transaction growth. I'm watching chip cycles, customer growth, semiconductor momentum, transaction volume, and margins.
0 · Reply
Scalpingstocks
Scalpingstocks Aug. 19 at 9:04 AM
$HIMS $HIMZ in a nice channel. Feels $HIMS gonna drop a decent news soon and uplift to mid $30 s . Well there's always the flip side of every story too. Never go all in. Trade in blocks and scalp the shit out of it. Of done right weekly 10%+ is not much yo ask for $
0 · Reply
HenryTabisula478
HenryTabisula478 Aug. 19 at 7:14 AM
$SNDQ $HIMS $SOXS $PYPL SNDQ provides semiconductor exposure, Hims & Hers benefits from digital-health demand, SOXS provides leveraged inverse semiconductor exposure, and PayPal remains tied to digital payments and transaction growth. I'm watching chip cycles, customer growth, semiconductor momentum, transaction volume, and margins.
0 · Reply
RaulCole522
RaulCole522 Aug. 19 at 7:09 AM
$HGRAF $KORU $LLY $HIMS HGRAF remains highly speculative, KORU remains speculative and execution-dependent, Eli Lilly benefits from strong obesity and diabetes-drug demand, and Hims & Hers benefits from digital-health adoption. I'm watching liquidity, prescription growth, customer additions, regulatory developments, and margins.
0 · Reply
wvegoneplaid
wvegoneplaid Aug. 19 at 5:18 AM
$HIMS
0 · Reply
wvegoneplaid
wvegoneplaid Aug. 19 at 5:08 AM
$HIMS
0 · Reply
thelasthope
thelasthope Aug. 19 at 1:35 AM
$HIMS Don't make such posts. Shorts think its negative and short more lol. Hims shorts are the dumbest bumch
0 · Reply
CapitalMonk
CapitalMonk Aug. 19 at 12:48 AM
$HIMS Price: $27.39 (-4.26%) Trend: Bullish Market Bias (7D): Bullish Bias 📈 Expected Range: ±1.68% RSI: 57.0 | Momentum: Moderate Volume: -48.6% vs avg Volatility: 6.72% Support: $24.24 | Resistance: $35.85 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
jdubh22a
jdubh22a Aug. 19 at 12:31 AM
$HIMS what happened , this board was very lively and active , ive been out for a few months loaded a few thousand today , will keep loading
0 · Reply
Latest News on HIMS
Watch CNBC's full interview with Hims & Hers CEO Andrew Dudum

Aug 18, 2026, 12:29 PM EDT - 19 hours ago

Watch CNBC's full interview with Hims & Hers CEO Andrew Dudum

HIMS

Hims & Hers CEO says FTC lawsuit misunderstands how the company works

Aug 18, 2026, 10:20 AM EDT - 21 hours ago

Hims & Hers CEO says FTC lawsuit misunderstands how the company works

HIMS

As Hims prepares for peptides launch, Wall Street cautious on prospects this year

Aug 12, 2026, 2:32 PM EDT - 6 days ago

As Hims prepares for peptides launch, Wall Street cautious on prospects this year

HIMS

Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)

Aug 12, 2026, 12:05 PM EDT - 6 days ago

Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS)

HIMS

Tuesday's Morning Movers: RKLB & HIMS Earnings, RIOT Gets Anthropic Deal

Aug 11, 2026, 10:30 AM EDT - 7 days ago

Tuesday's Morning Movers: RKLB & HIMS Earnings, RIOT Gets Anthropic Deal

HIMS RIOT RKLB

Hims & Hers shares slide as costly weight-loss push squeezes margins

Aug 11, 2026, 7:21 AM EDT - 8 days ago

Hims & Hers shares slide as costly weight-loss push squeezes margins

HIMS

AST SpaceMobile, Intel, On, Hims, and More Stocks That Explain Today's Market

Aug 11, 2026, 6:56 AM EDT - 8 days ago

AST SpaceMobile, Intel, On, Hims, and More Stocks That Explain Today's Market

ASTS HIMS INTC ONON

Hims & Hers stock drops 7% despite higher guidance: what went wrong?

Aug 11, 2026, 5:55 AM EDT - 8 days ago

Hims & Hers stock drops 7% despite higher guidance: what went wrong?

HIMS

Hims & Hers Health Earnings Call Transcript: Q2 2026

Aug 10, 2026, 5:00 PM EDT - 8 days ago

Hims & Hers Health Earnings Call Transcript: Q2 2026

Hims & Hers Health Slides: Q2 2026

Aug 10, 2026, 5:00 PM EDT - 8 days ago

Hims & Hers Health Slides: Q2 2026

Hims & Hers Health Earnings release: Q2 2026

Aug 10, 2026, 5:00 PM EDT - 8 days ago

Hims & Hers Health Earnings release: Q2 2026

Hims & Hers Health Quarterly report: Q2 2026

Aug 10, 2026, 5:00 PM EDT - 8 days ago

Hims & Hers Health Quarterly report: Q2 2026

Hims & Hers Health Boosts Revenue Target, Swings to Second-Quarter Loss

Aug 10, 2026, 4:41 PM EDT - 8 days ago

Hims & Hers Health Boosts Revenue Target, Swings to Second-Quarter Loss

HIMS

Hims & Hers raises annual forecast revenue on strong subscriber growth

Aug 10, 2026, 4:10 PM EDT - 8 days ago

Hims & Hers raises annual forecast revenue on strong subscriber growth

HIMS

Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results

Aug 10, 2026, 4:05 PM EDT - 8 days ago

Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results

HIMS

Raul Shah on HIMS Earnings Expectations & GLP-1 Wave's Lasting Stock Impacts

Aug 10, 2026, 12:30 PM EDT - 8 days ago

Raul Shah on HIMS Earnings Expectations & GLP-1 Wave's Lasting Stock Impacts

HIMS

Kaplan Fox Notifies Hims & Hers Health, Inc. (HIMS) Investors of a Securities Investigation into the Company

Aug 7, 2026, 9:00 AM EDT - 11 days ago

Kaplan Fox Notifies Hims & Hers Health, Inc. (HIMS) Investors of a Securities Investigation into the Company

HIMS

Lowey Dannenberg, P.C. is Investigating Hims & Hers Health, Inc. (NYSE: HIMS) for Potential Violations of the Federal Securities Laws

Aug 6, 2026, 12:22 PM EDT - 12 days ago

Lowey Dannenberg, P.C. is Investigating Hims & Hers Health, Inc. (NYSE: HIMS) for Potential Violations of the Federal Securities Laws

HIMS

Hims & Hers Introduces New Hers App with First-of-Its-Kind, Doctor-Led, AI-Native Care Experience

Aug 6, 2026, 9:00 AM EDT - 12 days ago

Hims & Hers Introduces New Hers App with First-of-Its-Kind, Doctor-Led, AI-Native Care Experience

HIMS

Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (HIMS)

Aug 5, 2026, 9:51 AM EDT - 13 days ago

Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (HIMS)

HIMS

Kaplan Fox Announces a Securities Investigation into Hims & Hers Health, Inc. (HIMS) - Investors Encouraged to Contact the Firm

Aug 3, 2026, 8:00 PM EDT - 15 days ago

Kaplan Fox Announces a Securities Investigation into Hims & Hers Health, Inc. (HIMS) - Investors Encouraged to Contact the Firm

HIMS

Market Matters Ep. 12: How HIMS Could Benefit From FDA Changes

Aug 3, 2026, 2:04 PM EDT - 15 days ago

Market Matters Ep. 12: How HIMS Could Benefit From FDA Changes

HIMS

HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with SBS Law

Jul 30, 2026, 1:58 PM EDT - 19 days ago

HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with SBS Law

HIMS

FTC sues Hims & Hers for allegedly sharing patients' medical data with advertisers Meta and Snap

Jul 30, 2026, 9:30 AM EDT - 19 days ago

FTC sues Hims & Hers for allegedly sharing patients' medical data with advertisers Meta and Snap

HIMS

Hims & Hers sent users' health data to social media giants despite promising privacy, bombshell FTC lawsuit claims

Jul 29, 2026, 6:05 PM EDT - 20 days ago

Hims & Hers sent users' health data to social media giants despite promising privacy, bombshell FTC lawsuit claims

HIMS

Wednesday's Final Takeaways: Fed Holds Rates & HIMS Lawsuit

Jul 29, 2026, 4:42 PM EDT - 20 days ago

Wednesday's Final Takeaways: Fed Holds Rates & HIMS Lawsuit

HIMS

Hims and Hers shares fall 10% as FTC sues company over data, billing practices

Jul 29, 2026, 2:24 PM EDT - 20 days ago

Hims and Hers shares fall 10% as FTC sues company over data, billing practices

HIMS

FTC Claims Hims & Hers Charged Patients Without Consent And Shared Health Data With Big Tech

Jul 29, 2026, 2:05 PM EDT - 20 days ago

FTC Claims Hims & Hers Charged Patients Without Consent And Shared Health Data With Big Tech

HIMS

Hims & Hers Responds to FTC Lawsuit

Jul 29, 2026, 1:51 PM EDT - 20 days ago

Hims & Hers Responds to FTC Lawsuit

HIMS

US FTC suing Hims & Hers for sending user health info to Meta, Snap

Jul 29, 2026, 12:34 PM EDT - 20 days ago

US FTC suing Hims & Hers for sending user health info to Meta, Snap

HIMS

Hims & Hers stands to gain if the FDA loosens restrictions on peptides

Jul 23, 2026, 6:03 AM EDT - 27 days ago

Hims & Hers stands to gain if the FDA loosens restrictions on peptides

HIMS

Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company

Jul 17, 2026, 4:17 PM EDT - 4 weeks ago

Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company

HIMS

Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

Jul 13, 2026, 4:05 PM EDT - 5 weeks ago

Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

HIMS

Amplify Online Retail ETF Rides a Summer Surge in Performance

Jul 2, 2026, 12:24 PM EDT - 6 weeks ago

Amplify Online Retail ETF Rides a Summer Surge in Performance

CART HIMS IBUY TRIP W

Hims & Hers stock jumps as Canaccord lifts target price ahead of FDA review

Jul 1, 2026, 2:15 PM EDT - 6 weeks ago

Hims & Hers stock jumps as Canaccord lifts target price ahead of FDA review

HIMS

Hims' obesity drug business may get boost as employers drop coverage

Jun 25, 2026, 6:04 AM EDT - 7 weeks ago

Hims' obesity drug business may get boost as employers drop coverage

HIMS

Living Longer Is Big Business. These Stocks Will Benefit.

Jun 18, 2026, 2:14 PM EDT - 2 months ago

Living Longer Is Big Business. These Stocks Will Benefit.

ABT DXCM GH HIMS PLNT

ChristineMartinez757
ChristineMartinez757 Aug. 19 at 9:15 AM
$HGRAF $KORU $LLY $HIMS HGRAF remains highly speculative, KORU remains speculative and execution-dependent, Eli Lilly benefits from strong obesity and diabetes-drug demand, and Hims & Hers benefits from digital-health adoption. I'm watching liquidity, prescription growth, customer additions, regulatory developments, and margins.
0 · Reply
NathanUziel1102
NathanUziel1102 Aug. 19 at 9:12 AM
$SNDQ $HIMS $SOXS $PYPL SNDQ provides semiconductor exposure, Hims & Hers benefits from digital-health demand, SOXS provides leveraged inverse semiconductor exposure, and PayPal remains tied to digital payments and transaction growth. I'm watching chip cycles, customer growth, semiconductor momentum, transaction volume, and margins.
0 · Reply
Scalpingstocks
Scalpingstocks Aug. 19 at 9:04 AM
$HIMS $HIMZ in a nice channel. Feels $HIMS gonna drop a decent news soon and uplift to mid $30 s . Well there's always the flip side of every story too. Never go all in. Trade in blocks and scalp the shit out of it. Of done right weekly 10%+ is not much yo ask for $
0 · Reply
HenryTabisula478
HenryTabisula478 Aug. 19 at 7:14 AM
$SNDQ $HIMS $SOXS $PYPL SNDQ provides semiconductor exposure, Hims & Hers benefits from digital-health demand, SOXS provides leveraged inverse semiconductor exposure, and PayPal remains tied to digital payments and transaction growth. I'm watching chip cycles, customer growth, semiconductor momentum, transaction volume, and margins.
0 · Reply
RaulCole522
RaulCole522 Aug. 19 at 7:09 AM
$HGRAF $KORU $LLY $HIMS HGRAF remains highly speculative, KORU remains speculative and execution-dependent, Eli Lilly benefits from strong obesity and diabetes-drug demand, and Hims & Hers benefits from digital-health adoption. I'm watching liquidity, prescription growth, customer additions, regulatory developments, and margins.
0 · Reply
wvegoneplaid
wvegoneplaid Aug. 19 at 5:18 AM
$HIMS
0 · Reply
wvegoneplaid
wvegoneplaid Aug. 19 at 5:08 AM
$HIMS
0 · Reply
thelasthope
thelasthope Aug. 19 at 1:35 AM
$HIMS Don't make such posts. Shorts think its negative and short more lol. Hims shorts are the dumbest bumch
0 · Reply
CapitalMonk
CapitalMonk Aug. 19 at 12:48 AM
$HIMS Price: $27.39 (-4.26%) Trend: Bullish Market Bias (7D): Bullish Bias 📈 Expected Range: ±1.68% RSI: 57.0 | Momentum: Moderate Volume: -48.6% vs avg Volatility: 6.72% Support: $24.24 | Resistance: $35.85 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
jdubh22a
jdubh22a Aug. 19 at 12:31 AM
$HIMS what happened , this board was very lively and active , ive been out for a few months loaded a few thousand today , will keep loading
0 · Reply
dogfisher
dogfisher Aug. 18 at 10:18 PM
$HIMS my LinkedIn feed is buzzing with leaders from the company talking about the exciting work happening and the type of talent they need to be truly transformational. Pretty amazing stuff.
0 · Reply
finestructure
finestructure Aug. 18 at 8:21 PM
$HIMS 25 would be great. I am not holding my breath but who knows. Someone always knows.
0 · Reply
DadSuggests
DadSuggests Aug. 18 at 8:04 PM
$HIMS I still have absolutely no idea why I can’t buy my creatine from HIMS.
0 · Reply
Marky_Mark2022
Marky_Mark2022 Aug. 18 at 7:52 PM
$HIMS just purchased 1,300 shares at $27.50, let's hope for $30 soon.
2 · Reply
easyx
easyx Aug. 18 at 7:46 PM
$HIMS such an easy buy loaded more cheers paper hands
0 · Reply
nnarum
nnarum Aug. 18 at 7:39 PM
$HIMS You know what, F it. Give me teens and maybe single digits. Market pullback is coming and high beta will not be a shelter. How far down is the question. Bullish long term, but the price action now is not in favor of the bulls.
0 · Reply
bullishoverbears
bullishoverbears Aug. 18 at 7:39 PM
$HIMS sorry bulls. We should’ve been in $OSCR this whole time instead
0 · Reply
bullishoverbears
bullishoverbears Aug. 18 at 7:24 PM
$HIMS that $28 rejection on the reclaim was telling. Most likely $25 this week
0 · Reply
MorganChase
MorganChase Aug. 18 at 6:56 PM
$HIMS 💵💵💵💵💵💎💎💎💎🎁🎁🎁🎁🎁🎁🎁🎁🎁🎁
1 · Reply
bullishoverbears
bullishoverbears Aug. 18 at 6:53 PM
$HIMS back to back times in the last 10min it gets over $28 and then immediately drops 10cents… someone is trying hard to not let it run
0 · Reply
ClarissaLove
ClarissaLove Aug. 18 at 6:25 PM
$HIMS Credit card sales are booming! 910M+ in the cards based on early data!
3 · Reply
bullishoverbears
bullishoverbears Aug. 18 at 6:23 PM
$HIMS are the bulls up for the challenge?
1 · Reply